T Hanninen
Overview
Explore the profile of T Hanninen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
2435
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Paajanen T, Hanninen T, Aitken A, Hallikainen M, Westman E, Wahlund L, et al.
Dement Geriatr Cogn Dis Extra
. 2014 Feb;
3(1):446-58.
PMID: 24516412
Background: Sensitive cognitive global scores are beneficial in screening and monitoring for prodromal Alzheimer's disease (AD). Early cortical changes provide a novel opportunity for validating established cognitive total scores against...
2.
Suhonen N, Kaivorinne A, Moilanen V, Bode M, Takalo R, Hanninen T, et al.
Neurocase
. 2014 Jan;
21(1):85-9.
PMID: 24417314
A hexanucleotide expansion in chromosome 9 open-reading frame 72 (C9ORF72) has been found to be a major cause of frontotemporal lobar degeneration (FTLD). We describe a 20-year follow-up of a...
3.
Hooshmand B, Solomon A, Kareholt I, Rusanen M, Hanninen T, Leiviska J, et al.
J Intern Med
. 2011 Nov;
271(2):204-12.
PMID: 22077644
Objectives: To examine the associations between serum homocysteine (tHcy), holotranscobalamin (holoTC, the biologically active fraction of vitamin B12) and folate and cognitive functioning in a longitudinal population-based study of Finnish...
4.
Sotaniemi M, Pulliainen V, Hokkanen L, Pirttila T, Hallikainen I, Soininen H, et al.
Acta Neurol Scand
. 2011 Jan;
125(1):16-23.
PMID: 21198445
Objectives: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) neuropsychological battery (nb) is used as an evaluation tool for dementia. In Finland, CERAD-nb was introduced in 1999 and...
5.
Seppala T, Herukka S, Hanninen T, Tervo S, Hallikainen M, Soininen H, et al.
J Neurol Neurosurg Psychiatry
. 2010 May;
81(10):1123-7.
PMID: 20478847
Background: Single measurements of plasma Aβ are not useful in the diagnostics of Alzheimer's disease (AD). However, changes in plasma Aβ levels during repeated testing may be helpful in the...
6.
Bendel P, Koivisto T, Aikia M, Niskanen E, Kononen M, Hanninen T, et al.
AJNR Am J Neuroradiol
. 2009 Nov;
31(2):370-6.
PMID: 19942696
Background And Purpose: Ventricular dilation and sulcal enlargement are common sequelae after aSAH. Our aim was to quantify the late ventricular dilation and volumes of the CSF spaces after aSAH...
7.
PET amyloid ligand [11C]PIB uptake and cerebrospinal fluid beta-amyloid in mild cognitive impairment
Koivunen J, Pirttila T, Kemppainen N, Aalto S, Herukka S, Jauhianen A, et al.
Dement Geriatr Cogn Disord
. 2008 Oct;
26(4):378-83.
PMID: 18931497
Background: In mild cognitive impairment (MCI), Alzheimer's disease (AD)-type cerebrospinal fluid (CSF) biomarker profiles predict rapid progression and conversion to AD. An increased brain amyloid burden in AD and MCI...
8.
Mustonen T, Koivisto T, Vanninen R, Hanninen T, Vapalahti M, Hernesniemi J, et al.
J Neurol Neurosurg Psychiatry
. 2008 Mar;
79(10):1128-33.
PMID: 18356250
Background And Purpose: Aneurysmal subarachnoid haemorrhage (aSAH) can be associated with acute global and regional decrease in cerebral perfusion. Furthermore, cerebral vasospasm may lead to development of delayed ischaemic deficits....
9.
Hamalainen A, Grau-Olivares M, Tervo S, Niskanen E, Pennanen C, Huuskonen J, et al.
Neurodegener Dis
. 2008 Mar;
5(3-4):186-9.
PMID: 18322386
Background: The apolipoprotein E (APOE) epsilon4 allele is a risk factor for Alzheimer's disease. Earlier studies have shown differences in brain structure according to the APOE epsilon4 status. Objective: To...
10.
Vanhanen M, Koivisto K, Moilanen L, Helkala E, Hanninen T, Soininen H, et al.
Neurology
. 2006 Sep;
67(5):843-7.
PMID: 16966548
Objective: To assess the association of metabolic syndrome (MetS) with Alzheimer disease (AD). Methods: The authors derived subjects from a population-based study of 980 randomly selected elderly subjects. After exclusion...